株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

肺疾患ドラッグデリバリー装置/システムの世界市場分析:製品 (MDI、DPI、ネブライザー、アクセサリ) 、用途、流通チャネル、エンドユース別

Pulmonary Drug Delivery Devices/Systems Market Analysis By Product (MDIs, DPIs, Nebulizers, Accessories), By Application, By Distribution Channel, By End-use, And Segment Forecasts, 2014 - 2025

発行 Grand View Research, Inc. 商品コード 557250
出版日 ページ情報 英文 135 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=114.58円で換算しております。
Back to Top
肺疾患ドラッグデリバリー装置/システムの世界市場分析:製品 (MDI、DPI、ネブライザー、アクセサリ) 、用途、流通チャネル、エンドユース別 Pulmonary Drug Delivery Devices/Systems Market Analysis By Product (MDIs, DPIs, Nebulizers, Accessories), By Application, By Distribution Channel, By End-use, And Segment Forecasts, 2014 - 2025
出版日: 2017年08月22日 ページ情報: 英文 135 Pages
概要

当レポートでは、世界の肺疾患ドラッグデリバリー装置/システム市場について調査し、市場の動向と製品別、用途別、流通チャネル別、エンドユース別、地域別動向、および市場に参入する主要企業のプロファイルなどをまとめています。

第1章 調査方法と範囲

第2章 エグゼクティブサマリー

第3章 市場変動、動向、範囲

  • 市場セグメンテーションと範囲
  • 市場促進因子分析
  • 市場阻害因子分析
  • 浸透および成長見通しマッピング
  • SWOT分析
  • ポーターのファイブフォース分析
  • 企業市場シェア

第4章 製品別市場

  • 動向分析
  • 定量吸入器
  • ドライパウダー吸入器
  • ネブライザー
  • アクセサリ

第5章 用途別市場

  • 動向分析
  • 喘息
  • 嚢胞性線維症
  • 慢性閉そく性肺疾患
  • アレルギー性鼻炎
  • その他

第6章 流通チャネル別市場

  • 動向分析
  • 小売り薬局
  • 院内薬局
  • 電子商取引

第7章 エンドユース別市場

  • 動向分析
  • 病院・診療所
  • 在宅ケア

第8章 地域別市場

  • 市場シェア
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ

第9章 競合環境

  • 戦略枠組み
  • 市場参入
  • 企業プロファイル
目次
Product Code: GVR-1-68038-587-8

The global pulmonary drug delivery devices/systems market is expected to reach USD 55.1 billion by 2025, according to a new report by Grand View Research, Inc., Increasing prevalence of chronic respiratory diseases is expected to boost the adoption of Pulmonary Drug Delivery Systems (PDDS). As per WHO, 235 million people suffer from asthma globally. Majority of the asthma related deaths occur in middle- to low-income countries due to lack of treatment options. This shows the potential demand for pulmonary drug delivery systems in the coming years.

Technological advancements in the field of drug delivery are expected to positively impact the pulmonary drug delivery devices market. These advancements include incorporation of agglomerated vesicle technology, MDI electronic dose counter, particle engineering, and supercritical fluid technology. Rising demand for new products, changing lifestyle, ease of use, and better facilities are factors expected to provide lucrative opportunities.

Furthermore, rise in number of public and private organizations is another major factor propelling the growth of pulmonary drug delivery devices market. For instance, organizations such as the Asia Pacific Association of Allergy, Asthma and Clinical Immunology (APAAACI) are engaged in providing information in clinical and basic research on allergy, asthma, and clinical immunology. Such initiatives are in turn expected to increase the market demand for respiratory drug delivery devices in developing regions, thereby boosting overall market growth.

Further Key Findings From the Study Suggest:

  • Metered dose inhaler segment held the dominant share owing to its low cost and high adoption rate due to early introduction in the market
  • Chronic Obstructive Pulmonary Diseases (COPD) segment is anticipated to grow at a lucrative CAGR due to the presence of favorable reimbursement policies for treatment of COPD
  • High number of patients affected by asthma in developing and developed regions is likely to support the development of asthma applications for respiratory drug delivery devices
  • E-commerce segment is expected to witness lucrative growth. Development of this segment is supported by its associated benefits such as convenience, discounts, and flexibility
  • Home care segment is expected to exhibit exponential growth due to the introduction of technologically advanced, portable, and small-sized devices that can be used at home
  • Asia Pacific region is anticipated to grow at a lucrative CAGR. High prevalence of COPD, indicating a substantial socioeconomic burden in this region drives the growth in Asia Pacific
  • The market is progressing due to the rising demand for better treatment options, efficient drug delivery, and rapid treatment of local respiratory disorders

Table of Contents

Chapter 1 Research Methodology

  • 1.1 Region Wise Market Calculation
    • 1.1.1 Region wise market: Base estimates
    • 1.1.2 Global market: CAGR calculation
  • 1.2 Research Scope & Assumptions
  • 1.3 List of Data Sources

Chapter 2 Executive Summary

  • 2.1 Market Snapshot

Chapter 3 Pulmonary Drug Delivery Systems Market Variables, Trends & Scope

  • 3.1 Market Segmentation & Scope
  • 3.2 Market Driver Analysis
    • 3.2.1 Increasing incidence of respiratory diseases
    • 3.2.2 Technological advancements
    • 3.2.3 Increasing initiatives from public and private organizations
  • 3.3 Market Restraint Analysis
    • 3.3.1 Regulatory issues and patent expiry of blockbuster drugs
  • 3.4 Penetration & Growth Prospect Mapping
  • 3.5 Pulmonary Drug Delivery Systems - SWOT Analysis, By Factor (political & legal, economic and technological)
  • 3.6 Industry Analysis - Porter's
  • 3.7 Company Market Share, 2016

Chapter 4 Pulmonary Drug Delivery Systems Market: Product Estimates & Trend Analysis

  • 4.1 Pulmonary Drug Delivery Systems Market: Product Movement Analysis
  • 4.2 Metered Dose Inhalers (MDIs)
    • 4.2.1 Metered dose inhalers (MDIs) market, 2014 - 2025 (USD Million)
  • 4.3 Dry Powder Inhalers (DPIs)
    • 4.3.1 Dry powder inhalers (DPIs)market, 2014 - 2025 (USD Million)
  • 4.4 Nebulizers
    • 4.4.1 Nebulizers market, 2014 - 2025 (USD Million)
    • 4.4.2 Mesh nebulizers
      • 4.4.2.1 Mesh nebulizers market, 2014 - 2025 (USD Million)
      • 4.4.2.2 Vibrating mesh nebulizers
      • 4.4.2.2.1 Vibrating mesh nebulizers market, 2014 - 2025 (USD Million)
      • 4.4.2.3 Static mesh nebulizers
      • 4.4.2.3.1 Static mesh nebulizers market, 2014 - 2025 (USD Million)
    • 4.4.3 Pneumatic nebulizers
      • 4.4.3.1 Pneumatic nebulizers market, 2014 - 2025 (USD Million)
      • 4.4.3.2 Vented pneumatic nebulizers
      • 4.4.3.2.1 Vented pneumatic nebulizers market, 2014 - 2025 (USD Million)
      • 4.4.3.3 Breath actuated pneumatic nebulizers
      • 4.4.3.3.1 Breath actuated pneumatic nebulizers market, 2014 - 2025 (USD Million)
    • 4.4.4 Ultrasonic nebulizers
      • 4.4.4.1 Ultrasonic nebulizers market, 2014 - 2025 (USD Million)
  • 4.5 Accessories
    • 4.5.1 Accessories market, 2014 - 2025 (USD Million)

Chapter 5 Pulmonary Drug Delivery Systems Market: Application Estimates & Trend Analysis

  • 5.1 Pulmonary Drug Delivery Systems Market: Application Movement Analysis
  • 5.2 Asthma
    • 5.2.1 Asthma market, 2014 - 2025 (USD Million)
  • 5.3 Cystic Fibrosis
    • 5.3.1 Cystic fibrosis market, 2014 - 2025 (USD Million)
  • 5.4 Chronic Obstructive Pulmonary Disease
    • 5.4.1 Chronic obstructive pulmonary disease market, 2014 - 2025 (USD Million)
  • 5.5 Allergic Rhinitis
    • 5.5.1 Allergic rhinitis market, 2014 - 2025 (USD Million)
  • 5.6 Others
    • 5.6.1 Others market, 2014 - 2025 (USD Million)

Chapter 6 Pulmonary Drug Delivery Systems Market: Distribution Channel Estimates & Trend Analysis

  • 6.1 Pulmonary Drug Delivery Systems Market: Distribution Channel Movement Analysis
  • 6.2 Retail Pharmacies
    • 6.2.1 Retail pharmacies market, 2014 - 2025 (USD Million)
  • 6.3 Hospital Pharmacies
    • 6.3.1 Hospital pharmacies market, 2014 - 2025 (USD Million)
  • 6.4 E-Commerce
    • 6.4.1 E-commercemarket, 2014 - 2025 (USD Million)

Chapter 7 Pulmonary Drug Delivery Systems Market: End Use Estimates & Trend Analysis

  • 7.1 Pulmonary Drug Delivery Systems Market: End Use Movement Analysis
  • 7.2 Hospitals & Clinics
    • 7.2.1 Hospitals & clinics market, 2014 - 2025 (USD Million)
  • 7.3 Homecare
    • 7.3.1 Homecare market, 2014 - 2025 (USD Million)

Chapter 8 Pulmonary Drug Delivery Systems Market: Regional Estimates & Trend Analysis, by Product, Application, Distribution Channel, and End Use

  • 8.1 Pulmonary Drug Delivery Systems Market Share by Region, 2016& 2025
  • 8.2 North America
    • 8.2.1 North America pulmonary drug delivery systems market, by country, 2014 - 2025 (USD Million)
    • 8.2.2 North America pulmonary drug delivery systems market, by product, 2014 - 2025 (USD Million)
    • 8.2.3 North America pulmonary drug delivery systems market, by application, 2014 - 2025 (USD Million)
    • 8.2.4 North America pulmonary drug delivery systems market, by distribution channel, 2014 - 2025 (USD Million)
    • 8.2.5 North America pulmonary drug delivery systems market, by end use, 2014 - 2025 (USD Million)
    • 8.2.6 U.S.
      • 8.2.6.1 U.S. pulmonary drug delivery systems market, by product, 2014 - 2025 (USD Million)
      • 8.2.6.2 U.S. pulmonary drug delivery systems market, by application, 2014 - 2025 (USD Million)
      • 8.2.6.3 U.S. pulmonary drug delivery systems market, by distribution channel, 2014 - 2025 (USD Million)
      • 8.2.6.4 U.S. pulmonary drug delivery systems market, by end use, 2014 - 2025 (USD Million)
    • 8.2.7 Canada
      • 8.2.7.1 Canada pulmonary drug delivery systems market, by product, 2014 - 2025 (USD Million)
      • 8.2.7.2 Canada pulmonary drug delivery systems market, by application, 2014 - 2025 (USD Million)
      • 8.2.7.3 Canada pulmonary drug delivery systems market, by distribution channel, 2014 - 2025 (USD Million)
      • 8.2.7.4 Canada pulmonary drug delivery systems market, by end use, 2014 - 2025 (USD Million)
  • 8.3 Europe
    • 8.3.1 Europe pulmonary drug delivery systems market, by country, 2014 - 2025 (USD Million)
    • 8.3.2 Europe pulmonary drug delivery systems market, by product, 2014 - 2025 (USD Million)
    • 8.3.3 Europe pulmonary drug delivery systems market, by application, 2014 - 2025 (USD Million)
    • 8.3.4 Europe pulmonary drug delivery systems market, by distribution channel, 2014 - 2025 (USD Million)
    • 8.3.5 Europe pulmonary drug delivery systems market, by end use, 2014 - 2025 (USD Million)
    • 8.3.6 UK
      • 8.3.6.1 UK pulmonary drug delivery systems market, by product, 2014 - 2025 (USD Million)
      • 8.3.6.2 UK pulmonary drug delivery systems market, by application, 2014 - 2025 (USD Million)
      • 8.3.6.3 UK pulmonary drug delivery systems market, by distribution channel, 2014 - 2025 (USD Million)
      • 8.3.6.4 UK pulmonary drug delivery systems market, by end use, 2014 - 2025 (USD Million)
    • 8.3.7 Germany
      • 8.3.7.1 Germany pulmonary drug delivery systems market, by product, 2014 - 2025 (USD Million)
      • 8.3.7.2 Germany pulmonary drug delivery systems market, by application, 2014 - 2025 (USD Million)
      • 8.3.7.3 Germany pulmonary drug delivery systems market, by distribution channel, 2014 - 2025 (USD Million)
      • 8.3.7.4 Germany pulmonary drug delivery systems market, by end use, 2014 - 2025 (USD Million)
  • 8.4 Asia Pacific
    • 8.4.1 Asia Pacific pulmonary drug delivery systems market, by country, 2014 - 2025 (USD Million)
    • 8.4.2 Asia Pacific pulmonary drug delivery systems market, by product, 2014 - 2025 (USD Million)
    • 8.4.3 Asia Pacific pulmonary drug delivery systems market, by application, 2014 - 2025 (USD Million)
    • 8.4.4 Asia Pacific pulmonary drug delivery systems market, by distribution channel, 2014 - 2025 (USD Million)
    • 8.4.5 Asia Pacific pulmonary drug delivery systems market, by end use, 2014 - 2025 (USD Million)
    • 8.4.6 Japan
      • 8.4.6.1 Japan pulmonary drug delivery systems market, by product, 2014 - 2025 (USD Million)
      • 8.4.6.2 Japan pulmonary drug delivery systems market, by application, 2014 - 2025 (USD Million)
      • 8.4.6.3 Japan pulmonary drug delivery systems market, by distribution channel, 2014 - 2025 (USD Million)
      • 8.4.6.4 Japan pulmonary drug delivery systems market, by end use, 2014 - 2025 (USD Million)
    • 8.4.7 China
      • 8.4.7.1 China pulmonary drug delivery systems market, by product, 2014 - 2025 (USD Million)
      • 8.4.7.2 China pulmonary drug delivery systems market, by application, 2014 - 2025 (USD Million)
      • 8.4.7.3 China pulmonary drug delivery systems market, by distribution channel, 2014 - 2025 (USD Million)
      • 8.4.7.4 China pulmonary drug delivery systems market, by end use, 2014 - 2025 (USD Million)
    • 8.4.8 India
      • 8.4.8.1 India pulmonary drug delivery systems market, by product, 2014 - 2025 (USD Million)
      • 8.4.8.2 India pulmonary drug delivery systems market, by application, 2014 - 2025 (USD Million)
      • 8.4.8.3 India pulmonary drug delivery systems market, by distribution channel, 2014 - 2025 (USD Million)
      • 8.4.8.4 India pulmonary drug delivery systems market, by end use, 2014 - 2025 (USD Million)
  • 8.5 Latin America
    • 8.5.1 Latin America pulmonary drug delivery systems market, by country, 2014 - 2025 (USD Million)
    • 8.5.2 Latin America pulmonary drug delivery systems market, by product, 2014 - 2025 (USD Million)
    • 8.5.3 Latin America pulmonary drug delivery systems market, by application, 2014 - 2025 (USD Million)
    • 8.5.4 Latin America pulmonary drug delivery systems market, by distribution channel, 2014 - 2025 (USD Million)
    • 8.5.5 Latin America pulmonary drug delivery systems market, by end use, 2014 - 2025 (USD Million)
    • 8.5.6 Brazil
      • 8.5.6.1 Brazil pulmonary drug delivery systems market, by product, 2014 - 2025 (USD Million)
      • 8.5.6.2 Brazil pulmonary drug delivery systems market, by application, 2014 - 2025 (USD Million)
      • 8.5.6.3 Brazil pulmonary drug delivery systems market, by distribution channel, 2014 - 2025 (USD Million)
      • 8.5.6.4 Brazil pulmonary drug delivery systems market, by end use, 2014 - 2025 (USD Million)
    • 8.5.7 Mexico
      • 8.5.7.1 Mexico pulmonary drug delivery systems market, by product, 2014 - 2025 (USD Million)
      • 8.5.7.2 Mexico pulmonary drug delivery systems market, by application, 2014 - 2025 (USD Million)
      • 8.5.7.3 Mexico pulmonary drug delivery systems market, by distribution channel, 2014 - 2025 (USD Million)
      • 8.5.7.4 Mexico pulmonary drug delivery systems market, by end use, 2014 - 2025 (USD Million)
  • 8.6 MEA
    • 8.6.1 MEA pulmonary drug delivery systems market, by country, 2014 - 2025 (USD Million)
    • 8.6.2 MEA pulmonary drug delivery systems market, by product, 2014 - 2025 (USD Million)
    • 8.6.3 MEA pulmonary drug delivery systems market, by application, 2014 - 2025 (USD Million)
    • 8.6.4 MEA pulmonary drug delivery systems market, by distribution channel, 2014 - 2025 (USD Million)
    • 8.6.5 MEA pulmonary drug delivery systems market, by end use, 2014 - 2025 (USD Million)
    • 8.6.6 South Africa
      • 8.6.6.1 South Africa pulmonary drug delivery systems market, by product, 2014 - 2025 (USD Million)
      • 8.6.6.2 South Africa pulmonary drug delivery systems market, by application, 2014 - 2025 (USD Million)
      • 8.6.6.3 South Africa pulmonary drug delivery systems market, by distribution channel, 2014 - 2025 (USD Million)
      • 8.6.6.4 South Africa pulmonary drug delivery systems market, by end use, 2014 - 2025 (USD Million)

Chapter 9 Competitive Landscape

  • 9.1 Strategy Framework
  • 9.2 Market Participation
  • 9.3 Company Profiles
    • 9.3.1 GlaxoSmithKline plc
      • 9.3.1.1 Company overview
      • 9.3.1.2 Financial performance
      • 9.3.1.3 Geographic foothold
      • 9.3.1.4 Product benchmarking
      • 9.3.1.5 Strategic initiatives
    • 9.3.2 Philips Respironics
      • 9.3.2.1 Company overview
      • 9.3.2.2 Financial performance
      • 9.3.2.3 Geographic foothold
      • 9.3.2.4 Product benchmarking
      • 9.3.2.5 Strategic initiatives
    • 9.3.3 Boehringer Ingelheim GmbH
      • 9.3.3.1 Company overview
      • 9.3.3.2 Financial performance
      • 9.3.3.3 Geographic foothold
      • 9.3.3.4 Product benchmarking
      • 9.3.3.5 Strategic initiatives
    • 9.3.4 Novartis AG
      • 9.3.4.1 Company overview
      • 9.3.4.2 Financial performance
      • 9.3.4.3 Geographic foothold
      • 9.3.4.4 Product benchmarking
      • 9.3.4.5 Strategic initiatives
    • 9.3.5 3M Healthcare
      • 9.3.5.1 Company overview
      • 9.3.5.2 Financial performance
      • 9.3.5.3 Product benchmarking
      • 9.3.5.4 Strategic initiatives
    • 9.3.6 GF Health Products, Inc.
      • 9.3.6.1 Company overview
      • 9.3.6.2 Financial performance
      • 9.3.6.3 Product benchmarking
    • 9.3.7 Merck & Co., Inc.
      • 9.3.7.1 Company overview
      • 9.3.7.2 Financial performance
      • 9.3.7.3 Geographic foothold
      • 9.3.7.4 Product benchmarking
    • 9.3.8 AstraZeneca
      • 9.3.8.1 Company overview
      • 9.3.8.2 Financial performance
      • 9.3.8.3 Geographic foothold
      • 9.3.8.4 Product benchmarking
      • 9.3.8.5 Strategic initiatives

List of Tables

  • TABLE 1 Country share estimation
  • TABLE 2 North America pulmonary drug delivery systems market, by country, 2014 - 2025 (USD Million)
  • TABLE 3 North America pulmonary drug delivery systems market, by product, 2014 - 2025 (USD Million)
  • TABLE 4 North America pulmonary drug delivery systems market, by application, 2014 - 2025 (USD Million)
  • TABLE 5 North America pulmonary drug delivery systems market, by distribution channel, 2014 - 2025 (USD Million)
  • TABLE 6 North America pulmonary drug delivery systems market, by end use, 2014 - 2025 (USD Million)
  • TABLE 7 U.S. pulmonary drug delivery systems market, by product, 2014 - 2025 (USD Million)
  • TABLE 8 U.S. pulmonary drug delivery systems market, by application, 2014 - 2025 (USD Million)
  • TABLE 9 U.S. pulmonary drug delivery systems market, by distribution channel, 2014 - 2025 (USD Million)
  • TABLE 10 U.S. pulmonary drug delivery systems market, by end use, 2014 - 2025 (USD Million)
  • TABLE 11 Canada pulmonary drug delivery systems market, by product, 2014 - 2025 (USD Million)
  • TABLE 12 Canada pulmonary drug delivery systems market, by application, 2014 - 2025 (USD Million)
  • TABLE 13 Canada pulmonary drug delivery systems market, by distribution channel, 2014 - 2025 (USD Million)
  • TABLE 14 Canada pulmonary drug delivery systems market, by end use, 2014 - 2025 (USD Million)
  • TABLE 15 Europe pulmonary drug delivery systems market, by country, 2014 - 2025 (USD Million)
  • TABLE 16 Europe pulmonary drug delivery systems market, by product, 2014 - 2025 (USD Million)
  • TABLE 17 Europe pulmonary drug delivery systems market, by application, 2014 - 2025 (USD Million)
  • TABLE 18 Europe pulmonary drug delivery systems market, by distribution channel, 2014 - 2025 (USD Million)
  • TABLE 19 Europe pulmonary drug delivery systems market, by end use, 2014 - 2025 (USD Million)
  • TABLE 20 UK pulmonary drug delivery systems market, by product, 2014 - 2025 (USD Million)
  • TABLE 21 UK pulmonary drug delivery systems market, by application, 2014 - 2025 (USD Million)
  • TABLE 22 UK pulmonary drug delivery systems market, by distribution channel, 2014 - 2025 (USD Million)
  • TABLE 23 UK pulmonary drug delivery systems market, by end use, 2014 - 2025 (USD Million)
  • TABLE 24 Germany pulmonary drug delivery systems market, by product, 2014 - 2025 (USD Million)
  • TABLE 25 Germany pulmonary drug delivery systems market, by application, 2014 - 2025 (USD Million)
  • TABLE 26 Germany pulmonary drug delivery systems market, by distribution channel, 2014 - 2025 (USD Million)
  • TABLE 27 Germany pulmonary drug delivery systems market, by end use, 2014 - 2025 (USD Million)
  • TABLE 28 Asia Pacific pulmonary drug delivery systems market, by country, 2014 - 2025 (USD Million)
  • TABLE 29 Asia Pacific pulmonary drug delivery systems market, by product, 2014 - 2025 (USD Million)
  • TABLE 30 Asia Pacific pulmonary drug delivery systems market, by application, 2014 - 2025 (USD Million)
  • TABLE 31 Asia Pacific pulmonary drug delivery systems market, by distribution channel, 2014 - 2025 (USD Million)
  • TABLE 32 Asia Pacific pulmonary drug delivery systems market, by end use, 2014 - 2025 (USD Million)
  • TABLE 33 Japan pulmonary drug delivery systems market, by product, 2014 - 2025 (USD Million)
  • TABLE 34 Japan pulmonary drug delivery systems market, by application, 2014 - 2025 (USD Million)
  • TABLE 35 Japan pulmonary drug delivery systems market, by distribution channel, 2014 - 2025 (USD Million)
  • TABLE 36 Japan pulmonary drug delivery systems market, by end use, 2014 - 2025 (USD Million)
  • TABLE 37 China pulmonary drug delivery systems market, by product, 2014 - 2025 (USD Million)
  • TABLE 38 China pulmonary drug delivery systems market, by application, 2014 - 2025 (USD Million)
  • TABLE 39 China pulmonary drug delivery systems market, by distribution channel, 2014 - 2025 (USD Million)
  • TABLE 40 China pulmonary drug delivery systems market, by end use, 2014 - 2025 (USD Million)
  • TABLE 41 India pulmonary drug delivery systems market, by product, 2014 - 2025 (USD Million)
  • TABLE 42 India pulmonary drug delivery systems market, by application, 2014 - 2025 (USD Million)
  • TABLE 43 India pulmonary drug delivery systems market, by distribution channel, 2014 - 2025 (USD Million)
  • TABLE 44 India pulmonary drug delivery systems market, by end use, 2014 - 2025 (USD Million)
  • TABLE 45 Latin America pulmonary drug delivery systems market, by country, 2014 - 2025 (USD Million)
  • TABLE 46 Latin America pulmonary drug delivery systems market, by product, 2014 - 2025 (USD Million)
  • TABLE 47 Latin America pulmonary drug delivery systems market, by application, 2014 - 2025 (USD Million)
  • TABLE 48 Latin America pulmonary drug delivery systems market, by distribution channel, 2014 - 2025 (USD Million)
  • TABLE 49 Latin America pulmonary drug delivery systems market, by end use, 2014 - 2025 (USD Million)
  • TABLE 50 Brazil pulmonary drug delivery systems market, by product, 2014 - 2025 (USD Million)
  • TABLE 51 Brazil pulmonary drug delivery systems market, by application, 2014 - 2025 (USD Million)
  • TABLE 52 Brazil pulmonary drug delivery systems market, by distribution channel, 2014 - 2025 (USD Million)
  • TABLE 53 Brazil pulmonary drug delivery systems market, by end use, 2014 - 2025 (USD Million)
  • TABLE 54 Mexico pulmonary drug delivery systems market, by product, 2014 - 2025 (USD Million)
  • TABLE 55 Mexico pulmonary drug delivery systems market, by application, 2014 - 2025 (USD Million)
  • TABLE 56 Mexico pulmonary drug delivery systems market, by distribution channel, 2014 - 2025 (USD Million)
  • TABLE 57 Mexico pulmonary drug delivery systems market, by end use, 2014 - 2025 (USD Million)
  • TABLE 58 MEA pulmonary drug delivery systems market, by country, 2014 - 2025 (USD Million)
  • TABLE 59 MEA pulmonary drug delivery systems market, by product, 2014 - 2025 (USD Million)
  • TABLE 60 MEA pulmonary drug delivery systems market, by application, 2014 - 2025 (USD Million)
  • TABLE 61 MEA pulmonary drug delivery systems market, by distribution channel, 2014 - 2025 (USD Million)
  • TABLE 62 MEA pulmonary drug delivery systems market, by end use, 2014 - 2025 (USD Million)
  • TABLE 63 South Africa pulmonary drug delivery systems market, by product, 2014 - 2025 (USD Million)
  • TABLE 64 South Africa pulmonary drug delivery systems market, by application, 2014 - 2025 (USD Million)
  • TABLE 65 South Africa pulmonary drug delivery systems market, by distribution channel, 2014 - 2025 (USD Million)
  • TABLE 66 South Africa pulmonary drug delivery systems market, by end use, 2014 - 2025 (USD Million)

List of Figures

  • FIG. 1 Market summary
  • FIG. 2 Market trends &outlook
  • FIG. 3 Market segmentation & scope
  • FIG. 4 Market driver relevance analysis (Current & future impact)
  • FIG. 5 Market restraint relevance analysis (Current & future impact)
  • FIG. 6 Penetration & growth prospect mapping
  • FIG. 7 SWOT Analysis, By Factor (political & legal, economic and technological)
  • FIG. 8 Porter's Five Forces Analysis
  • FIG. 9 Pulmonary drug delivery systems market: Company share analysis, 2016
  • FIG. 10 Pulmonary drug delivery systems market, product outlook: Key takeaways
  • FIG. 11 Pulmonary drug delivery systems market: Product movement analysis
  • FIG. 12 Metered dose inhalers (MDIs) market, 2014 - 2025 (USD Million)
  • FIG. 13 Dry powder inhalers (DPIs) market, 2014 - 2025 (USD Million)
  • FIG. 14 Nebulizers market, 2014 - 2025 (USD Million)
  • FIG. 15 Mesh nebulizers market, 2014 - 2025 (USD Million)
  • FIG. 16 Vibrating mesh nebulizers market, 2014 - 2025 (USD Million)
  • FIG. 17 Static mesh nebulizers market, 2014 - 2025 (USD Million)
  • FIG. 18 Pneumatic nebulizers market, 2014 - 2025 (USD Million)
  • FIG. 19 Vented pneumatic nebulizers market, 2014 - 2025 (USD Million)
  • FIG. 20 Breath actuated pneumatic nebulizers market, 2014 - 2025 (USD Million)
  • FIG. 21 Ultrasonic nebulizers market, 2014 - 2025 (USD Million)
  • FIG. 22 Accessories market, 2014 - 2025 (USD Million)
  • FIG. 23 Pulmonary drug delivery systems market, application outlook: Key takeaways
  • FIG. 24 Pulmonary drug delivery systems market: Application movement analysis
  • FIG. 25 Asthma market, 2014 - 2025 (USD Million)
  • FIG. 26 Cystic fibrosis market, 2014 - 2025 (USD Million)
  • FIG. 27 Chronic obstructive pulmonary disease market, 2014 - 2025 (USD Million)
  • FIG. 28 Allergic rhinitis market, 2014 - 2025 (USD Million)
  • FIG. 29 Others market, 2014 - 2025 (USD Million)
  • FIG. 30 Pulmonary drug delivery systems market, distribution channel outlook: Key takeaways
  • FIG. 31 Pulmonary drug delivery systems market: distribution channel movement analysis
  • FIG. 32 Retail pharmacies market, 2014 - 2025 (USD Million)
  • FIG. 33 Hospital pharmacies market, 2014 - 2025 (USD Million)
  • FIG. 34 E-commerce market, 2014 - 2025 (USD Million)
  • FIG. 35 Pulmonary drug delivery systems market, end use outlook: Key takeaways
  • FIG. 36 Pulmonary drug delivery systems market: End use movement analysis
  • FIG. 37 Hospitals & clinics market, 2014 - 2025 (USD Million)
  • FIG. 38 Homecare market, 2014 - 2025 (USD Million)
  • FIG. 39 Regional market place: Key takeaways
  • FIG. 40 Regional outlook, 2016 & 2025
  • FIG. 41 Strategy framework
  • FIG. 42 Market participation and categorization
Back to Top